This program looks at intrauterine pathologies and innovative technologies used to treat them. With a focus on mechanical hysteroscopic tissue removal and the clinical evidence supporting its use, this presentation reviews aspects of fertility optimization with the treatment of polyps, fibroids and retained products of conception.
- To obtain an understanding of intrauterine pathologies
- To identify types of technologies used to treat intrauterine pathologies and the benefits and limitations of each technology including mechanical hysteroscopic tissue removal (mHTR)
- To identify the advantages of using mHTR for treatment of retained products of conception (RPOC) and fertility outcomes
Dr. Jonathon Solnik, MD
Dr. Jonathon Solnik is the Head of Gynaecology and Minimally Invasive Surgery at Mount Sinai Hospital and Women’s College Hospital in Toronto. Although a native of Toronto, he served for 9 years as Division Director of Urogynecology and the Center of Excellence for Minimally Invasive Surgery at the Cedars-Sinai Medical Center in Los Angeles before joining the University of Toronto Department of Obstetrics and Gynaecology in 2015.